Susquehanna International Group, LLP Concert Pharmaceuticals, Inc. Call Options Transaction History

Susquehanna International Group, LLP

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$4.34 - $5.84 $73,780 - $99,280	-17,000 Reduced 57.43%	12,600 $73,000
Q3 2022 Nov 14, 2022	SELL	$4.27 - $7.2 $303,596 - $511,920	-71,100 Reduced 70.61%	29,600 $198,000
Q2 2022 Aug 15, 2022	BUY	$2.8 - $6.36 $221,200 - $502,440	79,000 Added 364.06%	100,700 $424,000
Q4 2021 Feb 14, 2022	BUY	$2.69 - $4.22 $58,373 - $91,574	21,700 New	21,700 $68,000
Q2 2020 Aug 14, 2020	SELL	$7.8 - $11.52 $397,020 - $586,368	-50,900 Closed	0 $0

Q1 2020 May 15, 2020	BUY	$5.98 - $13.09 $224,848 - $492,184	37,600 Added 282.71%	50,900 $450,000
Q4 2019 Feb 14, 2020	SELL	$5.71 - $9.22 $46,822 - $75,604	-8,200 Reduced 38.14%	13,300 $123,000
Q2 2019 Aug 14, 2019	SELL	$9.44 - $13.12 $50,032 - $69,536	-5,300 Reduced 19.78%	21,500 $258,000
Q1 2019 May 15, 2019	BUY	$12.07 - $17.54 $56,729 - $82,438	4,700 Added 21.27%	26,800 $323,000
Q3 2018 Nov 14, 2018	BUY	$12.82 - $17.88 $42,306 - $59,004	3,300 Added 17.55%	22,100 $328,000
Q2 2018 Aug 14, 2018	SELL	$16.83 - $21.66 $565,488 - $727,776	-33,600 Reduced 64.12%	18,800 $316,000
Q1 2018 May 15, 2018	BUY	$19.24 - $28.03 $840,787 - $1.22 Million	43,700 Added 502.3%	52,400 $1.2 Million
Q4 2017 Feb 14, 2018	SELL	$13.96 - $29.05 $315,496 - $656,530	-22,600 Reduced 72.2%	8,700 $225,000
Q3 2017 Nov 14, 2017	BUY	$13.91 - $15.31 $435,383 - $479,203	31,300	31,300 $462,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.